Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-dose Chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00012311
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00141700
What this trial is testing

Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin's
University of Michigan Rogel Cancer Center 30
Not applicableStudy completedNCT00736021
What this trial is testing

Treatment of Post-traumatic Stress Disorder With High Doses of Escitalopram

Who this might be right for
Stress Disorders, Post Traumatic
Hadassah Medical Organization 38
Testing effectiveness (Phase 2)Study completedNCT01069081
What this trial is testing

Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastasis, Neoplasm
Fudan University 94
Large-scale testing (Phase 3)UnknownNCT00004128
What this trial is testing

Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 2,000
Early research (Phase 1)UnknownNCT00003412
What this trial is testing

Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation

Who this might be right for
Breast Cancer
Beth Israel Deaconess Medical Center 35
Testing effectiveness (Phase 2)Ended earlyNCT00003432
What this trial is testing

Immunotherapy in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Duke University 4
Testing effectiveness (Phase 2)UnknownNCT01172912
What this trial is testing

High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorTesticular Germ Cell Tumor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 47
Large-scale testing (Phase 3)UnknownNCT00011921
What this trial is testing

Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
EBMT Solid Tumors Working Party 430
Large-scale testing (Phase 3)Study completedNCT00002836
What this trial is testing

Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 184
Large-scale testing (Phase 3)Study completedNCT00398411
What this trial is testing

Moxifloxacin in the Prevention of Bacteremia After High-dose Chemotherapy and Transplantation of Peripheral Stem Cells

Who this might be right for
Hodgkin DiseaseNon-Hodgkin LymphomaMultiple Myeloma+1 more
University of Cologne 66
Early research (Phase 1)Study completedNCT03042793
What this trial is testing

Vaccination With PD-L1 Peptide Against Multiple Myeloma

Who this might be right for
Multiple Myeloma
Lene Meldgaard Knudsen 10
Testing effectiveness (Phase 2)Study completedNCT00002521
What this trial is testing

Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Temple University
Large-scale testing (Phase 3)Looking for participantsNCT06513065
What this trial is testing

Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)

Who this might be right for
Pseudomyxoma Peritonei
University of Southampton 176
Testing effectiveness (Phase 2)UnknownNCT01148173
What this trial is testing

High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas

Who this might be right for
Lymphoma, Non-Hodgkin
Charite University, Berlin, Germany 30
Early research (Phase 1)UnknownNCT03086291
What this trial is testing

A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy

Who this might be right for
Stomach Cancer
Samsung Medical Center 9
Testing effectiveness (Phase 2)Ended earlyNCT05167370
What this trial is testing

High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors

Who this might be right for
Solid TumorsBrain Tumors
Children's Hospital Medical Center, Cincinnati 2
Not applicableStudy completedNCT00577096
What this trial is testing

Effects of Exercise in Combination With Epoetin Alfa

Who this might be right for
Multiple Myeloma
University of Arkansas 120
Testing effectiveness (Phase 2)WithdrawnNCT03579927
What this trial is testing

CAR.CD19-CD28-zeta-2A-iCasp9-IL15-Transduced Cord Blood NK Cells, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Participants With B-cell Lymphoma

Who this might be right for
CD19 PositiveMantle Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma+4 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00006258
What this trial is testing

Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma

Who this might be right for
Brain and Central Nervous System Tumors
Children's Hospital Los Angeles
Next Page